BTSG, SANM and STX made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 9th, 2026.
BrightSpring Health Services, Inc. (BTSG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Here is how BrightSpring Health Services, Inc. (BTSG) and C4 Therapeutics, Inc. (CCCC) have performed compared to their sector so far this year.
BTSG, HUBS and STX made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 5, 2026.
BrightSpring Health Services, Inc. (BTSG) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
STRL, HLIO, TBLA, BTSG and XP have been added to the Zacks Rank #1 (Strong Buy) List on March 5, 2026.
BTSG, XP and CPRX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 4, 2026.
BrightSpring Health Services, Inc. (BTSG) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Investors with an interest in Medical Services stocks have likely encountered both BrightSpring Health Services, Inc. (BTSG) and Caris Life Sciences,?Inc. (CAI). But which of these two stocks presents investors with the better value opportunity right now?
BrightSpring Health Services, Inc. (BTSG) Q4 2025 Earnings Call Transcript
BrightSpring Health Services, Inc. (BTSG) came out with quarterly earnings of $0.33 per share, missing the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.22 per share a year ago.
BTSG is set to report Q4 earnings with strong pharmacy growth, steady provider gains and improving margins.